Completed NA INTERVENTIONAL 2-arm NCT07022730

Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension

The Novel Use of Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension in Patients With Surgical Sepsis, a Double Blind Randomized Controlled Trial

Sponsor: Cairo University

Conditions Post Induction Hypotension Sepsis

Interventions Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction

Updated 2 times since 2025 Last updated: Sep 17, 2025 Started: Jun 22, 2025 Primary completion: Sep 17, 2025 Completion: Sep 17, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Post Induction Hypotension and Sepsis and is currently completed. Cairo University leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2025 — Oct 2025 [monthly]

Recruiting NA

First recorded

Jun 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt